AmarGPintoMD

PubMed

• Altered first-pass effects in a liver transplant recipient explained intraindividual variation in calcineurin inhibitor concentrations: a case report.
  Malireddy, S. R., Pinto, A. G., Chalasani, N. P., Gorski, J. C., Hall, S. D.> ;Transplantation proceedings. 2008 Jul 1
• Severe thrombocytopenia due to hypersplenism successfully treated with partial splenic embolization in preoperative management.
  > ;South Med J. 2005 Apr
• Inhibition of human intestinal wall metabolism by macrolide antibiotics: effect of clarithromycin on cytochrome P450 3A4/5 activity and expression.
  > ;Clin Pharmacol Ther. 2005 Mar
• Effect of cirrhosis and liver transplantation on the gender difference in QT interval.
  Adigun, A. Q., Pinto, A. G., Flockhart, D. A., Gorski, J. C., Li, L., Hall, S. D., Chalasani, N.> ;The American journal of cardiology. 2005 Feb 22
• 1 citation
  Association between the CYP3A5 genotype and blood pressure.
  Ho, H., Pinto, A., Hall, S. D., Flockhart, D. A., Li, L., Skaar, T. C., Cadman, P. E., O'Connor, D. T., Wagner, U., Fineberg, N. S., Weinberger, M. H.> ;Hypertension (Dallas, Tex. : 1979). 2004 Dec 15
• 13 citations
  Severe but reversible cholestatic liver injury after pioglitazone therapy.
  Pinto, A. G., Cummings, O. W., Chalasani, N.> ;Annals of internal medicine. 2002 Nov 19
• 50 citations
  Model for end-stage liver disease (MELD) for predicting mortality in patients with acute variceal bleeding.
  Chalasani, N., Kahi, C. J., Francois, F., Pinto, A., Marathe, A., Bini, E. J., Pandya, P., Sitaraman, S., Shen, J.> ;Hepatology (Baltimore, Md.). 2002 May 1
• Join now to see all